Keywords: سرطان آندومتر; endometrial cancer; postmenopausal bleeding and heavy menstrual bleeding; health policy; women’s health; unopposed estrogen
مقالات ISI سرطان آندومتر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان آندومتر; Endometrial cancer; Ovarian cancer; Synchronous; Massively parallel sequencing (MPS); Copy number alteration
Keywords: سرطان آندومتر; Colorectal cancer; Retrospective cohort study; Insurance data; Breast cancer; Endometrial cancer; Ovarian cancer
The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer
Keywords: سرطان آندومتر; Endometrial cancer; Disease staging; Sentinel lymph node mapping; Indocyanine green;
Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma
Keywords: سرطان آندومتر; HOMER2; endometrial cancer; endometrioid adenocarcinoma; immunoexpression; low grade; prognostic factor;
High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome
Keywords: سرطان آندومتر; Tripartite motif-containing protein 44; TRIM44; Endometrial cancer; Metastasis; Prognosis;
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting report
Keywords: سرطان آندومتر; Endometrial cancer; Serous; Clinical trial; Molecular target;
Increased plasmatic soluble HLA-G levels in endometrial cancer
Keywords: سرطان آندومتر; Soluble human leukocyte antigen-G; Endometrial cancer; sHLA-G1; HLA-G5;
Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer
Keywords: سرطان آندومتر; Endometrial cancer; Outcomes research;
Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data
Keywords: سرطان آندومتر; TFAP2B; Endometrial cancer; Prognosis; TCGA; GSEA;
Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors
Keywords: سرطان آندومتر; Endometrial cancer; Obesity; Fitbit; Physical activity tracker; Wearable technology;
A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis
Keywords: سرطان آندومتر; Phase II clinical trial; Endometrial cancer; Irinotecan; Chemotherapy;
Does MMR status in endometrial cancer influence response to adjuvant therapy?
Keywords: سرطان آندومتر; Endometrial cancer; Mismatch repair; Recurrence;
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study
Keywords: سرطان آندومتر; Endometrial cancer; Recurrence risk groups; Sentinel node mapping; Lymphadenectomy;
RING domain of zinc finger protein like 1 is essential for cell proliferation in endometrial cancer cell line RL95-2
Keywords: سرطان آندومتر; EC; endometrial cancer; ZFPL1; zinc finger protein like 1; RING; really interesting new gene; EdU; 5-ethynyl-2â²-deoxyuridine; MTT; diphenyl tetrazolium bromide; Endometrial cancer; Zinc finger protein like 1; RL95-2; Cell proliferation; PI3K/Akt pathway
Second primary malignancies after high-dose-rate 60Co photon or 252Cf neutron brachytherapy in conjunction with external-beam radiotherapy for endometrial cancer
Keywords: سرطان آندومتر; 60Co; 252Cf; Neutron brachytherapy; Endometrial cancer; Second primary malignancies;
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial
Keywords: سرطان آندومتر; Endometrial cancer; Randomized trial; Brachytherapy; Molecular-integrated risk profiles; Radiotherapy; Prognostic factors;
Prediction of histological grade of endometrial cancer by means of MRI
Keywords: سرطان آندومتر; EC; endometrial cancer; MRI; magnetic resonance imaging; T2-WI; T2-weighted images; CET1-WI; contrast-enhanced T1-weighted images; DWI; diffusion-weighted images; ADC; apparent diffusion coefficient; N/U; neoplasm/uterus volume ratio; ROC; receiver-operat
Telephone follow-up after treatment for endometrial cancer: A qualitative study of patients' and clinical nurse specialists' experiences in the ENDCAT trial
Keywords: سرطان آندومتر; Telephone follow-up; Clinical nurse-specialist; Holistic care; Information needs; Endometrial cancer;
Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
Keywords: سرطان آندومتر; Stage I; Endometrial cancer; Brachytherapy; High-intermediate risk;
miR-152 inhibits proliferation of human endometrial cancer cells via inducing G2/M phase arrest by suppressing CDC25B expression
Keywords: سرطان آندومتر; miR-152; CDC25B; Cell proliferation; Cell cycle; Endometrial cancer;
Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model
Keywords: سرطان آندومتر; Endometrial cancer; Uterine cancer; Alternative payment models; Cost;
PET/MR hybrid imaging of cervical and endometrial cancer
Keywords: سرطان آندومتر; PET/MRI; Hybrid imaging; Cervical cancer; Endometrial cancer;
Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications
Keywords: سرطان آندومتر; Endometrial cancer; Lymphatic metastases; Lymphadenectomy; Lymphatic system; Sentinel lymph node biopsy; Indocyanine green; Lymphedema; Lymphocele; Chylous ascites;
Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma
Keywords: سرطان آندومتر; Endometrial cancer; Risk stratification; Prognostic; Modelling; ASRGL1; p53;
Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis
Keywords: سرطان آندومتر; Endometrial cancer; Chemoradiotherapy; Radiotherapy; Systematic review; Meta-analysis;
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
Keywords: سرطان آندومتر; Endometrial cancer; Paclitaxel; Carboplatin; Bevacizumab; Temsirolimus; Ixabepilone;
Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients
Keywords: سرطان آندومتر; Adjuvant radiotherapy; Endometrial cancer; Stage IIIC;
Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology
Keywords: سرطان آندومتر; Endometrial cancer; Clear cell; Papillary serous; Carcinosarcoma; Brachytherapy; Chemotherapy;
Réalité de la prise en charge du cancer de l'endomètre chez les patientes en obésité morbide : étude française bicentrique
Keywords: سرطان آندومتر; Cancer de l'endomètre; Traitement chirurgical; Faisabilité; Obésité morbide; Endometrial cancer; Surgical management; Faisability; Morbid obesity;
Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP)
Keywords: سرطان آندومتر; Alternative Payment Model; Endometrial cancer; Payment reform;
ER and PR expression and survival after endometrial cancer
Keywords: سرطان آندومتر; Endometrial cancer; Survival; Hormone receptor status; ER; PR;
ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
Keywords: سرطان آندومتر; ROR2; ROR1; Endometrial cancer; Uterine cancer; Wnt signalling;
Membrane progesterone receptors β and γ have potential as prognostic biomarkers of endometrial cancer
Keywords: سرطان آندومتر; EC; endometrial cancer; mPR; membrane progesterone receptors; PAQR; adipoQ receptor; qPCR; quantitative real-time PCR; FIGO; International Federation of Gynecology and Obstetrics; TMA; tissue microarrays;; MAPK; mitogen-activated protein kinases; Membrane
Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer
Keywords: سرطان آندومتر; Endometrial cancer; Peritoneal cytology; Recurrence; Low risk; Survival;
The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma
Keywords: سرطان آندومتر; EpCAM; Endometrial cancer; Tumor metastasis; Poor prognosis; ERα;
While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularity
Keywords: سرطان آندومتر; endometrial cancer; progesterone analogs; wait time to surgery;
Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancer
Keywords: سرطان آندومتر; Endometrial cancer; Tumor size; Magnetic resonance imaging (MRI); Tumor grade; Lymphovascular space invasion;
Hormone replacement therapy in cancer survivors: Utopia?
Keywords: سرطان آندومتر; Hormone replacement therapy; Risk of gynecological cancers; Ovarian cancer; Breast cancer; Endometrial cancer; Cancer survivors;
No 291 - Ãpidémiologie et explorations visant la présence soupçonnée d'un cancer de l'endomètre
Keywords: سرطان آندومتر; Endometrial cancer; diagnostic workup; endometrial evaluation; ultrasound; magnetic resonance imaging; MRI; postmenopausal bleeding; DC; Dilatation-curetage; HNPCC; Cancer colorectal héréditaire sans polypose;
No 249-Ãpaississement endométrial asymptomatique
Keywords: سرطان آندومتر; Asymptomatic endometrial thickening; asymptomatic endometrial polyp; endometrial cancer; transvaginal ultrasonography; hysteroscopy; endometrial biopsy tamoxifen; postmenopausal polyps; ÃTV; Ãchographie transvaginale; HT; Hormonothérapie;
Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database
Keywords: سرطان آندومتر; cytology; endometrial cancer; prognosis; survival;
Gynaecological neoplasms in common familial syndromes (Lynch and HBOC)
Keywords: سرطان آندومتر; Lynch; MMR; endometrial cancer; BRCA; ovarian cancer; screening;
Risk Factors for Unsuccessful Office-Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage
Keywords: سرطان آندومتر; Endometrial hyperplastic disease; Endometrial cancer; Pipelle failure;
MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: A systematic review of the literature
Keywords: سرطان آندومتر; MELF; Endometrial cancer; Lymph node metastasis; Myometrial invasion;
The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review
Keywords: سرطان آندومتر; Bevacizumab; Cervical cancer; Endometrial cancer; Ovarian cancer;
FDG-PET Assessment of Other Gynecologic Cancers
Keywords: سرطان آندومتر; Positron emission tomography (PET); Positron emission tomography/computed tomography (PET/CT); Endometrial cancer; Vulvar cancer; Vaginal cancer; Uterine cancer; Uterine sarcoma;
Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a
Keywords: سرطان آندومتر; NIFK-AS1; Endometrial cancer; Tumor-associated macrophages; MiR-146a; Notch1;
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey
Keywords: سرطان آندومتر; REM score; BMI; Endometrial cancer; Score; Nomogram; Ultrasound; HE4; REM-B;
Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome
Keywords: سرطان آندومتر; Familial Colon Cancer; Endometrial Cancer; Genetics; Protocol Integration; CI; confidence interval; CRC; colorectal cancer; LS; Lynch syndrome; MMR; mismatch repair; PREMM; Prediction of MLH1, MSH2, and MSH6;